Hydrocortisone

Product NDC
66267-966
11-digit product format
662670966
Labeler code
66267
Product ID
66267-966_9cae12dc-49db-2247-e053-2995a90a7599
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Hydrocortisone
Dosage form
CREAM
Route
TOPICAL
Labeler
NuCare Pharmaceuticals,Inc.
Application
ANDA089682
Marketing category
ANDA
Marketing start
2002-09-30
Marketing end
0000-00-00
Substance
HYDROCORTISONE
Active strength
25 mg/g
Pharmacologic classes
Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]
NDC exclude flag
No
Listing certified through
2021-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct66267-966DDiscontinued by firm2026-07-31
excluded packagepackage66267-96666267-966-20DDiscontinued by firm2026-07-31

Orange Book products#

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A089682-001HYDROCORTISONEHYDROCORTISONE2.5%CREAM / TOPICAL1988-03-10

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
HydrocortisoneHYDROCORTISONENuCare Pharmaceuticals,Inc.720357e2-6f01-737d-e053-2a95a90ae54b2024-06-10Adverse reactionsExact identifier
HydrocortisoneHYDROCORTISONEA-S Medication Solutions5ee2f62a-d8d5-4efd-bf6f-f79c108556312023-11-22Adverse reactionsExact identifier
HydrocortisoneHYDROCORTISONEProficient Rx LPd50240db-f630-4008-a272-55ba5c9913042022-07-01Adverse reactionsExact identifier

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

adverse reactions

ADVERSE REACTIONS The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in approximate decreasing order of occurrence: burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae and miliaria. To report SUSPECTED ADVERSE EVENTS, contact the FDA at 1-800-FDA-1088 or http://www.fda.gov/ for voluntary reporting of adverse reactions.

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
66267-966-20GM - Gram66267-9669f117415-a6b7-439a-92bf-5a267c910ab312018-01-12